Breaking News

Pinpointing why rapid Covid tests are missing cases; more top hospitals aren’t offering Aduhelm

 

Daily Recap

Scientists try to pinpoint why rapid Covid tests are missing some cases

By Matthew Herper

Adobe

Omicron may collect in the throat, not in the nose, which could be why nasal swabs in rapid testing kits often aren't detecting the variant.

Read More

STAT+: 'It's almost negligible': More top hospitals aren't offering controversial Alzheimer's drug Aduhelm

By Nicholas Florko

Alex Hogan/STAT

STAT has identified another 15 major, university-affiliated hospitals that aren’t offering the controversial new Alzheimer's drug Aduhelm.

Read More

Provocative new findings suggest a surprising cause of Down syndrome: cells linked to aging

By Megan Molteni

Courtesy Hiruy Meharena

MIT scientists may have found a surprising culprit for Down syndrome: senescent cells, the same types implicated in many diseases of aging.

Read More

3 fatal rabies cases in U.S. suggest public underestimates infection risks

By Helen Branswell

Charlie Riedel/AP

Rabies is virtually always a fatal infection if not treated, but treatment is highly effective if given early enough.

Read More

STAT+: Blueprint Medicines seeks 'continuity, not change' in CEO transition

By Adam Feuerstein

Courtesy Blueprint Medicines

Current CEO Jeff Albers will become executive chairman in April and current Chief Operating Officer Kate Haviland will succeed Albers as CEO.

Read More

STAT+: Institutional investors urge pharma boards to tie executive compensation to global Covid vaccine equity

By Ed Silverman

FREDERIC J. BROWN/AFP via Getty Images

Institutional investors are urging pharma boards to tie executive compensation to meeting goals on global access to Covid-19 vaccines.

Read More

Opinion: Recognizing obesity as a disease, not a choice, is a step toward health equity

By Fatima Cody Stanford and Kelly Copes-Anderson

Patrick Sison/AP

It's time to take action on the Treat and Reduce Obesity Act, which will help people with obesity get the treatment they need.

Read More

Opinion: Containing Covid-19 requires rapid tests that are highly sensitive to infections. Why is the FDA asking for something different?

By Elliott J. Millenson

Scott Olson/Getty Images

The key marker of effectiveness for home Covid-19 tests should be few false negatives, rather than the fewest false positives.

Read More

Thursday, January 6, 2022

STAT

Facebook   Twitter   YouTube   Instagram

1 Exchange Pl, Suite 201, Boston, MA 02109
©2022, All Rights Reserved.
I no longer wish to receive STAT emails
Update Email Preferences | Contact Us | View In Browser

No comments